Jinwan Wang
Chinese Academy Of Medical Sciences And Peking Union Medical College
Beijing, 100021, China
Beijing, 100021, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
Vorolanib, an oral VEGFR/PDGFR dual tyrosine kinase inhibitor for treatment of patients with advanced solid tumors: An open-label, phase I dose escalation and dose expansion trial.
Journal: Chinese journal of cancer research = Chung-kuo yen cheng yen chiu
Published: March 12, 2021
Efficacy and safety of anlotinib in patients with advanced malignancy: a single-center, single-arm, phase 2 trial.
Journal: International journal of clinical oncology
Published: December 27, 2020
A phase III, randomized, double-blind, controlled trial of carboxyamidotriazole plus chemotherapy for the treatment of advanced non-small cell lung cancer.
Journal: Therapeutic advances in medical oncology
Published: May 31, 2020
Anlotinib for Patients With Metastatic Renal Cell Carcinoma Previously Treated With One Vascular Endothelial Growth Factor Receptor-Tyrosine Kinase Inhibitor: A Phase 2 Trial.
Journal: Frontiers in oncology
Published: December 16, 2019
Pazopanib versus sunitinib in Chinese patients with locally advanced or metastatic renal cell carcinoma: pooled subgroup analysis from the randomized, COMPARZ studies.
Journal: BMC cancer
Published: March 08, 2019
Anlotinib Versus Sunitinib as First-Line Treatment for Metastatic Renal Cell Carcinoma: A Randomized Phase II Clinical Trial.
Journal: The oncologist
Published: November 30, 2018
Anlotinib for the Treatment of Patients with Locally Advanced or Metastatic Medullary Thyroid Cancer.
Journal: Thyroid : official journal of the American Thyroid Association
Published: August 26, 2018
Safety and Efficacy of Anlotinib, a Multikinase Angiogenesis Inhibitor, in Patients with Refractory Metastatic Soft-Tissue Sarcoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: December 19, 2017
Association Between Use of Traditional Chinese Medicine Herbal Therapy and Survival Outcomes in Patients With Stage II and III Colorectal Cancer: A Multicenter Prospective Cohort Study.
Journal: Journal of the National Cancer Institute. Monographs
Published: November 21, 2016
Safety, pharmacokinetics, and antitumor properties of anlotinib, an oral multi-target tyrosine kinase inhibitor, in patients with advanced refractory solid tumors.
Journal: Journal of hematology & oncology
Published: July 06, 2016
Characteristics of recurrence in patients with gastric cancer after radical gastrectomy and adjuvant chemotherapy
Journal: Zhonghua zhong liu za zhi [Chinese journal of oncology]
Published: December 31, 2015
Last Updated: 09/26/2026